About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Two Imaging Agents Developed Can Monitor Tumour Growth Better

by Hannah Joy on October 5, 2017 at 11:05 AM
Font : A-A+

Two Imaging Agents Developed Can Monitor Tumour Growth Better

Two new imaging agents have been created to aid physicians visualize the formation of tumour-associated blood vessels, to keep track of the tumour growth and can also generate new therapies, reveals a new study.

"Blood vessel growth is critical to tumour growth," said John Lewis, the Alberta Cancer Foundation Frank and Carla Sojonky Chair in Prostate Cancer Research at the U of A and a member of the Cancer Research Institute of Northern Alberta (CRINA).

Advertisement


UAlberta researchers said, "When a tumour starts growing, cells start to divide out of control and they lack an organized blood vessel network to feed them. When that happens, there are help signals that tell the surrounding blood vessels to branch off and supply the tumour with new blood vessels for oxygen and nutrients."

The process is called angiogenesis. There are a number of approved cancer drugs to prevent the formation of new tumour-related blood vessels, but according to Lewis, many haven't yet lived up to their promise due to wide variability among patients.
Advertisement

He believes the newly created imaging agents, which can be used in PET scans and fluorescence imaging, could provide physicians helpful insight when determining the best course of action for their patients.

"These drugs can be toxic and expensive, but potentially life-saving for certain patients. An imaging agent could be used before treatment to see how many new blood vessels are forming to determine whether an individual patient is a candidate for treatments that will inhibit new blood vessel growth. This would allow treatment to be personalized for those patients most likely to respond. Also, during the treatment, you could use the same imaging agent to monitor the response to the therapy."

In his research, Lewis, along with collaborators at Western University and Case Western Reserve University, worked with a protein, EGFL7, that is specific to actively growing blood vessels. Together they created new peptides that home into EGFL7 to test if they would be useful for imaging purposes.

"Once we had the peptide, we validated in two ways," said Lewis. "First we did some PET imaging of mice tumours and the peptide localized to those tumours and lit them up. We also created nanoparticles with the peptide and they were able to accumulate in the new blood vessels and light them up as well."

The imaging agents now need to be tested in a treatment setting. Lewis plans to begin that work in animal models before moving on to clinical work in humans. His aim is to provide new tools which will help doctors make better and quicker treatment decisions for their patients.

"Ideally we would get a measure of response 24 hours after we first give the drug," said Lewis.

"Currently we measure any changes in tumour size up to a month after treatment, which is a long time to wait to find out if an expensive drug isn't working."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Turmeric: Magic Ingredient to Keep you Healthy in Winter
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cysts and Tumours Tumor Markers For Cancer Diagnosis and Prognosis 

Recommended Reading
Tumour Growth Mechanism Goes a Step Further
New study suggests that loss of a particular tumour-suppressing protein causes abnormal growth of .....
Aging, Inflammation Hastened by Cancer Cells to 'Feed' Tumour Growth
Cancer cells accelerate aging of nearby connective tissue cells to cause inflammation, which ......
Mutated Protein Linked to Tumour Growth
A protein that is a major target of a gene that, when mutated in humans, causes tumors to develop .....
New Target For Developing Anti-Angiogenic And Anti-Tumoral Therapies:CNIO Researchers
Antibody-based blocking of ephrinB2, a protein involved in angiogenesis and lymphoangiogenesis, may ...
Cysts and Tumours
Ultrasound scan reveals multiple cysts and there is no function on that kidney when tested on DMSA s...
Tumor Markers For Cancer Diagnosis and Prognosis
An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use